| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |